Young, Jim; Schäfer, Juliane; Fux, Christoph A; Furrer, Hansjakob; Bernasconi, Enos; Vernazza, Pietro; Calmy, Alexandra; Cavassini, Matthias; Weber, Rainer; Battegay, Manuel; Bucher, Heiner C; Swiss HIV Cohort Study, (2012). Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir. AIDS, 26(5), pp. 567-75. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/QAD.0b013e32834f337c
Full text not available from this repository.Tenofovir is associated with reduced renal function, but it is not clear whether there is a greater decline in renal function when tenofovir is co-administered with a boosted protease inhibitor rather than with a nonnucleoside reverse transcriptase inhibitor (NNRTI).
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology |
UniBE Contributor: |
Furrer, Hansjakob |
ISSN: |
0269-9370 |
Publisher: |
Lippincott Williams & Wilkins |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:37 |
Last Modified: |
05 Dec 2022 14:11 |
Publisher DOI: |
10.1097/QAD.0b013e32834f337c |
PubMed ID: |
22398568 |
Web of Science ID: |
000301333000006 |
URI: |
https://boris.unibe.ch/id/eprint/14958 (FactScience: 222101) |
Actions (login required)
 |
Edit item |